EHC vs ENSG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EHC Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Encompass Health Corporation Common Stock (EHC) driven by superior Valuation, Growth & Margin, Momentum & Technical while ENSG counters with relative strength in Options & Structure. Fundamentally, EHC trades at 19.4x Forward P/E with 18.4% operating margin (+8.9% YoY revenue) versus ENSG at 20.1x Forward P/E and 8.8% operating margin (+14.5% YoY). In options structure, EHC sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against ENSG sits in CONSOLIDATION (62nd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | EHC Revenue | ENSG Revenue | EHC Op. Margin | ENSG Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $4.28B | $1.75B | 13.0% | 4.8% | EHC |
| FY2019 | $4.61B | $2.04B | 13.3% | 6.3% | EHC |
| FY2020 | $3.57B | $2.39B | 15.8% | 9.3% | EHC |
| FY2021 | $4.01B | $2.63B | 13.9% | 9.9% | EHC |
| FY2022 | $4.35B | $3.03B | 12.4% | 9.8% | EHC |
| FY2023 | $4.80B | $3.71B | 7.3% | 6.9% | EHC |
| FY2024 | $5.37B | $4.24B | 8.5% | 8.5% | Tie |
| FY2025 | $5.94B | $5.03B | 9.5% | 8.5% | EHC |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EHC | ENSG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $13.0B | $10.3B | Larger Scale | EHC |
| Trailing P/E Ratio Valuation | 21.2x | 26.3x | Lower Multiple | EHC |
| Forward P/E Ratio Valuation | 19.4x | 20.1x | Lower Multiple | EHC |
| Revenue Growth (YoY) Growth | +8.9% | +14.5% | Higher Growth | ENSG |
| Operating Margin (TTM) Profitability | 18.4% | 8.8% | Higher Margin | EHC |
| Net Profit Margin Profitability | 10.2% | 7.0% | Higher Margin | EHC |
| Return on Equity (ROE) Capital Efficiency | 25.1% | 17.1% | Higher ROE | EHC |
| 52-Week Range Position Momentum | 80% ($93โ$144) | 46% ($142โ$218) | Stronger Trend | EHC |
| Beta / 30D Volatility Risk Regime | -0.10ฮฒ ยท 40% Vol | 0.12ฮฒ ยท 42% Vol | Lower Realized Risk | EHC |
| Unified Institutional Score Composite Signal | 52.0 / 100 (HOLD) | 48.3 / 100 (HOLD) | Higher Composite | EHC |